D3 Medicine Limited Liability Company is categorized under Noncommercial Biotechnical Research in Parsippany, NJ and active since 2013.
D3 Medicine Limited Liability Company was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Patrick Smith at the company’s single location by writing to 4 Navajo Court, Parsippany, New Jersey NJ 07054 or by phoning (973) 267-4703. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | D3 Medicine Limited Liability Company |
| Contact Person: | Patrick Smith |
| Address: | 4 Navajo Court, Parsippany, New Jersey 07054 |
| Phone Number: | (973) 267-4703 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biotechnical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
D3 Medicine Limited Liability Company was started in 2013 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Patrick Smith for inquiries that concern D3 Medicine Limited Liability Company by calling the company number (973) 267-4703, as your correspondence is most welcome. Additionally, the physical location of the single location of D3 Medicine Limited Liability Company can be found at the coordinates as well as the street address 4 Navajo Court in Parsippany, New Jersey 07054.
For its online presence, you may visit D3 Medicine Limited Liability Company’s website at and engage with its social media outlets through on Twitter and on Facebook.